Key Developments: Nestle SA (NESN.VX)

NESN.VX on Virt-X Level 1

67.55CHF
31 Jul 2014
Price Change (% chg)

CHF-0.75 (-1.10%)
Prev Close
CHF68.30
Open
CHF68.20
Day's High
CHF68.30
Day's Low
CHF67.45
Volume
6,054,663
Avg. Vol
4,813,498
52-wk High
CHF72.05
52-wk Low
CHF60.50

Search Stocks

Latest Key Developments (Source: Significant Developments)

Nestle SA completed acquisition of Valeant Pharmaceuticals's commercialisation rights
Thursday, 10 Jul 2014 09:35am EDT 

Nestle SA:Completed its acquisition of Valeant Pharmaceuticals International's commercialisation rights to several key injectable aesthetic dermatology products in US and Canada, as announced on May 28.These rights will be integrated into NestlĂ© Skin Health and commercialised by Galderma.  Full Article

L'Oreal finalizes disposal of its 50 pct ownership in Galderma to Nestle
Tuesday, 8 Jul 2014 12:00pm EDT 

L'Oreal SA:Finalizes disposal of its 50 pct ownership in Galderma to Nestle.  Full Article

Valeant Pharmaceuticals International Inc to sell Filler And Toxin assets to Nestle
Wednesday, 28 May 2014 01:15am EDT 

Valeant Pharmaceuticals International Inc:Agreement to sell all rights to Restylane, Perlane, Emervel, Sculptra, and Dysport owned or held by Valeant for $1.4 bln in cash.Nestle expects to complete acquisition of Galderma S.A. in July and would expect to operate acquired assets through Galderma.Transaction is subject to customary closing conditions, including clearance or early expiration of waiting period under Hart-Scott-Rodino (HSR) Act and is not contingent upon successful transaction with Allergan, Inc.Transaction is extremely attractive both to Valeant and Galderma, and dovetails well with our announced plans for a transaction with Allergan.  Full Article

Nestle SA confirms FY 2014 outlook
Tuesday, 15 Apr 2014 02:00am EDT 

Nestle SA:Confirms fiscal 2014 outlook.Says performance will be weighted to second half, outperforming market, with organic growth around 5 pct. and improvements in margins, underlying earnings per share (EPS) in constant currencies and capital efficiency.  Full Article

Nestle SA Chairman to step down from his position in 2017
Saturday, 5 Apr 2014 12:07am EDT 

Nestle SA:Says Chairman Peter Brabeck-Letmathe to step down form his position in 2017.  Full Article

L'Oreal and Nestle sign mixed share purchase agreement
Monday, 24 Mar 2014 03:30am EDT 

L'Oreal SA:Says to have signed on March 21 mixed share purchase agreement with Nestle SA to acquire 48,500,000 own shares, representing 8 pct of share capital.Acquisition conditioned upon sale to Nestle of company's holding in Galderma.Sale completion conditional upon approval of competition authorities.  Full Article

BioGaia extends agreement with Nestle
Wednesday, 12 Mar 2014 03:00am EDT 

BioGaia AB:Enters into a supplementary agreement to the original from Feb. 2012 with Nestle SA.Says in Feb. 2012 it sold the rights for the use of Lactobacillus reuteri Protectis in infant formula to Nestle for the remainder of the patent lifetime.Says the supplementary agreement provides BioGaia with royalties of around 92 million Swedish crowns (about 10.4 million euros) over a three-year period, starting during the second quarter, for which BioGaia will carry out specific clinical studies in the pediatric area.Says in addition it will develop new products for Nestle in new areas.Says the development will include both pre-clinical and clinical studies as well as product development.Says if the development is successful, these products will be produced by BioGaia and sold to Nestle.Says the agreement also means that BioGaia will immediately receive the remaining milestone payments totalling 7.2 million euros from the 2012 agreement.  Full Article

Nestle SA proposes FY 2013 dividend and issues FY 2014 financial outlook
Wednesday, 12 Feb 2014 07:00pm EST 

Nestle SA:Says board will propose an increase in the dividend to 2.15 Swiss francs per share for FY 2013.The last trading day with entitlement to receive the dividend is April 11.The net dividend will be payable as from April 17.FY 2012 dividend was of 2.05 Swiss francs per share.Expect FY 2014 performance to be similar to last year.Expects growth around 5 pct and improvements in margins, underlying earnings per share in constant currencies and capital efficiency.  Full Article

L'Oreal SA buys back 8 percent of its share capital from Nestle SA
Tuesday, 11 Feb 2014 12:02am EST 

L'Oreal SA and Nestle SA:Say L'Oreal will buy 48.5 million of its own shares (8 percent of its share capital) from Nestle.Say the buyback will be financed partially through the disposal by L'Oreal to Nestle of its stake in Galderma (a 50/50 joint venture between L'Oreal and Nestle) for an enterprise value of 3.1 billion euros (2.6 billion euros of equity value), paid by Nestle in L'Oreal shares (21.2 million shares).The remaining 27.3 million L'Oreal shares held by Nestle will be paid for in cash for an amount of 3.4 billion euros.The price per L'Oreal share is 124.48 euros.All the shares bought back by L'Oreal will be cancelled.Nestle's stake in L'Oreal will be reduced from 29.4 percent to 23.29 percent.The Bettencourt Meyers family's stake will go from 30.6 percent to 33.31 percent.The transaction will be accretive by more than 5 percent on L'Oreal's recurring earnings per share on a full year basis.  Full Article

Nestle SA sells PowerBar, its sports nutrition business
Monday, 3 Feb 2014 08:19am EST 

Nestle SA:Says it has sold its sports nutrition business under the PowerBar and Musashi brands to a US-based consumer packed goods holding company, Post Holdings.  Full Article

Corporate price cutting highlights European deflation threat

LONDON, July 29 - Weak consumer spending and intense competition among retailers are forcing some makers of packaged goods to lower their prices, intensifying the threat of euro zone deflation.

Search Stocks